A recent multi-centre audit of prescribing and administration of community intravenous (IV) therapy across the East and South East of England, demonstrated that there was often inefficient and unsafe transfer of patients from acute to community services. Most referrals had some important therapy or patient details missing e.g. allergy status was omitted in 20% of referrals and 11% of patients experienced avoidable delays in treatment as a result of problems with supplies. The majority of community IV therapy is prescribed by hospital doctors who therefore take medico-legal responsibility for the treatment that is administered in the community.
This guide is designed to help an acute trust pharmacist follow up a small cohort of patients who were discharged to receive a course of IV therapy in the community.
- To prospectively assess the quality of discharge information/prescriptions for patients referred for community IV therapy
- To identify problems with supplies of medicines
- To identify any problems with the process for clinical review of patients, post-discharge
- To provide assurance of the quality of care for these patients and make recommendations for improvements, where appropriate.